logo

For the Inventor, By the Inventor

Moreland Hills, OH, United States of America

Michael A Weiss

This inventor holds 31 USPTO granted patents and 19 published patent applications, primarily in Insulin Analogues. Top assignees: Case Western Reserve University, Thermalin Diabetes, Inc., Thermalin, Inc.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael A Weiss. Retrieved from https://idiyas.com/inventor/michael-a-weiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 48.4

Average Co-Inventor Count = 1.1

ph-index = 4

Forward Citations = 88(Granted Patents)


Location History:

  • Cleveland, OH (US) (2018 - 2020)
  • Indianapolis, IN (US) (2020 - 2021)
  • Moreland Hills, OH (US) (2012 - 2023)

Company Filing History:

goldMedal29 out of 1,364 
 
Case Western Reserve University
 patents
silverMedal1 out of 1 
 
Thermalin Diabetes, Inc.
 patent
bronzeMedal1 out of 1 
 
Thermalin, Inc.
 patent

Years Active: 2012-2025

Loading Chart...
Areas of Expertise:
Rapid-Acting Insulin
Insulin Stability
Single-Chain Analogues
Biphasic Formulations
Non-Standard Insulin
Fibrillation Resistance
Chlorinated Amino Acids
Pharmaceutical Delivery
Long-Acting Insulin
Conformational Switch
Mitogenicity Reduction
Ultra-Concentrated Formulations
31 patents (USPTO):Explore Patents
1. 12312390 - Rapid-acting insulin analogues of enhanced stability (2025-05-27),
2. 11583572 - Encapsulation of ultra-stable insulin analogues with polymer melts (2023-02-21),
3. 11208453 - Rapid-acting insulin analogues of enhanced stability (2021-12-28),
4. 11174303 - Single-chain insulin analogues stabilized by a fourth disulfide bridge (2021-11-16),
5. 11142560 - Biphasic single-chain insulin analogues (2021-10-12),
6. 10995129 - Non-standard insulin analogues (2021-05-04),
7. 10822386 - Insulin analogues with enhanced stability and reduced mitogenicity (2020-11-03),
8. 10745458 - Non-standard insulin analogues (2020-08-18),
9. 10703792 - Insulin analogues with selective signaling properties and reduced mitogenicity (2020-07-07),
10. 10584156 - Insulin analogues with a glucose-regulated conformational switch (2020-03-10),
11. 10561711 - Rapid action insulin formulations and pharmaceutical delivery systems (2020-02-18),
12. 10472406 - Insulin analogues with selective signaling properties and reduced mitogenicity (2019-11-12),
13. 10392429 - Biphasic single-chain insulin analogues (2019-08-27),
14. 10138284 - Non-standard insulin analogues (2018-11-27),
15. 9975940 - Long-acting single-chain insulin analogues (2018-05-22),

Title: The Innovative Journey of Michael A. Weiss

Introduction: Michael A. Weiss, a distinguished inventor hailing from Moreland Hills, Ohio, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Michael A. Weiss holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on enhancing user experience in digital platforms and improving medical devices for better patient outcomes.

Career Highlights: Throughout his illustrious career, Michael A. Weiss has been recognized for his creativity and problem-solving skills. He has received numerous awards for his innovative work, showcasing his dedication to pushing the boundaries of technology and design.

Collaborations: Michael A. Weiss has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have led to the development of cutting-edge products that have revolutionized their respective industries.

Conclusion: In conclusion, Michael A. Weiss stands as a visionary inventor who continues to inspire others with his passion for innovation. His relentless pursuit of excellence and commitment to creating a better future through his inventions make him a true pioneer in the world of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…